ACS Names Daisy Fernandez Seebach Chief Ethics Officer

DALLAS, Jan. 22 /PRNewswire-FirstCall/ -- Affiliated Computer Services, Inc. , a premier provider of business process outsourcing and information technology solutions, announced today that Daisy Fernandez Seebach will join the Company January 23, 2007, as Vice President and Chief Ethics Officer. In her new role, Seebach will report to President and Chief Executive Officer Lynn Blodgett and provide strategic focus on the ethics and values of the Company's business around the world. She will also coordinate and communicate ethics activities, as well as implement and monitor programs that detect and prevent unethical or illegal conduct.

"As a respected leader of a global industry, ACS must serve as a model of integrity, compliance, and self-governance. Bringing Daisy on board emphasizes the prominent role our Ethics Office has in our day-to-day operations and improves our ability to meet our commitments to our clients, employees, and shareholders," Blodgett said.

"We are excited to have Daisy join the ACS team. She brings unique experience and insight, and her depth of knowledge will be a tremendous asset as we strengthen ourselves as a world-class company and provide more and better opportunities for our people to grow," he said.

Seebach has more than 25 years of labor and employment law, ethics, compliance, and administration experience, most recently as the Senior Ethics Officer and Ombudsman at Merck & Co., Inc. In that role, she assisted employees in resolving work-related issues and in managing ethics and compliance matters, both domestically and internationally. Prior to that, she served as assistant counsel in Merck's Employment and Labor Group and held other positions with international responsibilities in the areas of privacy law and human resources. She was also responsible for the development and implementation of worldwide human resources privacy and data protection policies and other procedures regarding privacy, compliance, and corporate ethics.

"Our long-term success depends on the confidence we have in each other," Seebach said. "I look forward to helping ACS continue to develop and protect strong relationships with our clients, employees, and shareholders as we pursue opportunity and growth."

Before joining Merck, Seebach served as an attorney specializing in immigration, employment, and family law with several firms in New York and Florida. She holds a Bachelor of Arts degree from the College of New Rochelle and earned her Juris Doctor degree from the Hofstra University School of Law. She is a member of the Florida and New York Bar Associations and is admitted to practice in the United States District Courts for the Eastern and Southern Districts of New York. She is also a member of several professional organizations and serves as the Chairperson of the Health Care Industry Committee of the Ethics and Compliance Officers Association.

ACS, a global FORTUNE 500 company with 58,000 people supporting client operations reaching 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. The Company's Class A common stock trades on the New York Stock Exchange under the symbol "ACS". ACS makes technology work. Visit ACS on the Internet at http://www.acs-inc.com/ .

The statements in this news release that do not directly relate to historical facts constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to numerous risks and uncertainties, many of which are outside the Company's control. As such, no assurance can be given that the actual events and results will not be materially different than the anticipated results described in the forward-looking statements. Factors could cause actual results to differ materially from such forward-looking statements. For a description of these factors, see the Company's prior filings with the Securities and Exchange Commission, including our most recent filing. ACS disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future event, or otherwise.